Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2010
03/18/2010WO2010029312A1 Carbohydrate binding molecules
03/18/2010WO2010029302A2 Compounds for treating viral infections
03/18/2010WO2010029196A1 Antibacterial peptide compounds
03/18/2010WO2010029104A2 Use of a pharmaceutical composition for the local treatment of infections, and medical product
03/18/2010WO2010029003A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029001A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029000A1 Triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010028862A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010WO2010028798A1 Multivalent antibodies
03/18/2010WO2010028797A1 Multivalent antibodies
03/18/2010WO2010028796A1 Trispecific hexavalent antibodies
03/18/2010WO2010028795A1 Multivalent antibodies
03/18/2010WO2010028676A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent
03/18/2010WO2010028674A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028673A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028672A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028671A1 Use of opiorphin as a therapeutic agent
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010028542A1 Pleuromutilin phosphate, its pharmaceutical composition, preparation method and uses thereof
03/18/2010WO2010011622A9 Ophthalmic gallium compositions and methods of their use
03/18/2010WO2010010172A3 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity
03/18/2010WO2009149264A3 Anti-bacterial composition and method of using same
03/18/2010WO2009136979A3 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010WO2009132209A3 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
03/18/2010WO2009129305A3 Prodrugs of neuraminidase inhibitors
03/18/2010WO2009120339A3 Vectors for delivering disease neutralizing agents
03/18/2010WO2009087622A3 Sldlr in viral hepatitis
03/18/2010WO2009074133A3 C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof
03/18/2010WO2009061395A3 Hcv combination therapies comprising vx-950, peg-ifn and ribavirin
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069464 Compositions and methods for modulating activity of capped small rnas
03/18/2010US20100069455 Bone model, bone filler and process for producing bone filler
03/18/2010US20100069449 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
03/18/2010US20100069441 Antimicrobial indoline compounds for treatment of bacterial infections
03/18/2010US20100069420 Spiro-piperidine inhibitors
03/18/2010US20100069410 acyclovir formulations
03/18/2010US20100069380 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof
03/18/2010US20100069376 5-hydroxymethyl-oxazolidin-2-one antibacterials
03/18/2010US20100069366 Antibacterial quinoline derivatives
03/18/2010US20100069353 Inhibitors of hiv replication
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069322 Inhibition of cholera toxins by galatooligosaccharides (gos)
03/18/2010US20100069308 Surfaces containing antibacterial polymers
03/18/2010US20100069294 Hcv protease inhibitors and uses thereof
03/18/2010US20100068695 Inhibitor for enzyme having two divalent metal ions as active center
03/18/2010US20100068306 Compositions for accelerating the healing response
03/18/2010US20100068297 Antimicrobial Composition
03/18/2010US20100068258 Prophylactic tuberculosis vaccine
03/18/2010US20100068251 Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
03/18/2010US20100068244 Stabilized biodegradable neurotoxin implants
03/18/2010US20100068230 also comprises nucleic acid molecule (modified by contact with a psoralen activated by ultraviolet radiation) encoding non-Listerial antigen; immunogens; antigen presenting cells
03/18/2010US20100068229 Recombinant antigens of human cytomegalovirus (hcmv)
03/18/2010US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
03/18/2010US20100068227 Composition Useful as a Vaccine
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068224 Method for Producing Viral Vaccine and Therapeutic Peptide Antigens
03/18/2010US20100068223 Storage of Influenza Vaccines Without Refrigeration
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100068219 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/18/2010US20100068217 Epitope-transplant scaffolds and their use
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068176 Hepatitis c virus inhibitors
03/18/2010US20100068157 Oral compositions, their preparation and use
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/18/2010CA2736773A1 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition
03/18/2010CA2736488A1 Elimination of a contaminating non-human sialic acid by metabolic competition
03/18/2010CA2736295A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
03/17/2010EP2163557A1 Function-selective vitamin d receptor agonist
03/17/2010EP2163553A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
03/17/2010EP2163255A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
03/17/2010EP2162437A1 Enrofloxacin-hexahydrate
03/17/2010EP2162150A1 Vaccine against clostridium perfringens
03/17/2010EP2162146A2 Use of transferrin for preparing pharmaceutical compositions useful for treating bacterial infections as coadjuvants in antibiotic therapy
03/17/2010EP2162130A1 Triazol compounds for treating biofilm formation
03/17/2010EP1948666B1 Hiv integrase inhibitors
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1689795B1 Method of manufacture of polyacrolein
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1385870B1 Peptides as ns3-serine protease inhibitors of hepatitis c virus
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010EP1091971B1 Polyketide synthesis
03/17/2010EP0833923B2 Immunogenic construct, process for its preparation and use as a vaccine
03/17/2010CN101674849A N-halogenated amino acid formulations
03/17/2010CN101674848A N-halogenated amino acid formulations and methods for cleaning and disinfection
03/17/2010CN101671695A Recombinant vaccinia virus of Tiantan strain with IFN-gamma receptor gene (B8R) deletion and applications thereof
03/17/2010CN101671654A Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof
03/17/2010CN101671638A New strain of bifidobacterium and fermentative preparation method and application thereof
03/17/2010CN101671599A Health-care Chinese herb spice
03/17/2010CN101671390A Human interferon alpha derivatives and preparation and use of pegylated products thereof
03/17/2010CN101671385A Triterpene glycosides antifungal compounds of sea cucumber HolotoxinD-I and preparation method thereof
03/17/2010CN101671367A Pleuromutilin phosphate compounds, medicinal composition thereof, preparation method thereof and application thereof
03/17/2010CN101671351A Carbon 2-bit substituted cephalosporin derivative as well as synthetic method and application thereof
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 1798